Multiple Assemblies exist for SMTL entry 6ft0
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-425; X-RAY DIFFRACTION 2.10 Å

	SMTL ID 6ft0.1 Ligands ZINC ION; MAGNESIUM ION; 1,2-ETHANEDIOL; 4-{4-methoxy-3-[(2-methoxyphenyl)methoxy]phenyl}-2-(1-{thieno[3,2-d]pyrimidin-4-yl}piperidin-4-yl)-1,2,4a,5,8,8a-hexahydrophthalazin-1-one; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID Polypeptides cAMP-specific 3',5'-cyclic phosphodiesterase 4D Oligo-state monomer
	SMTL ID 6ft0.2 Ligands ZINC ION; MAGNESIUM ION; 1,2-ETHANEDIOL; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; 4-{4-methoxy-3-[(2-methoxyphenyl)methoxy]phenyl}-2-(1-{thieno[3,2-d]pyrimidin-4-yl}piperidin-4-yl)-1,2,4a,5,8,8a-hexahydrophthalazin-1-one Polypeptides cAMP-specific 3',5'-cyclic phosphodiesterase 4D Oligo-state monomer
	SMTL ID 6ft0.3 Ligands 1,2-ETHANEDIOL; ZINC ION; MAGNESIUM ION; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; 4-{4-methoxy-3-[(2-methoxyphenyl)methoxy]phenyl}-2-(1-{thieno[3,2-d]pyrimidin-4-yl}piperidin-4-yl)-1,2,4a,5,8,8a-hexahydrophthalazin-1-one Polypeptides cAMP-specific 3',5'-cyclic phosphodiesterase 4D Oligo-state monomer
	SMTL ID 6ft0.4 Ligands 1,2-ETHANEDIOL; ZINC ION; MAGNESIUM ION; DI(HYDROXYETHYL)ETHER; 4-{4-methoxy-3-[(2-methoxyphenyl)methoxy]phenyl}-2-(1-{thieno[3,2-d]pyrimidin-4-yl}piperidin-4-yl)-1,2,4a,5,8,8a-hexahydrophthalazin-1-one; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID Polypeptides cAMP-specific 3',5'-cyclic phosphodiesterase 4D Oligo-state monomer